Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.96 | -10.22 |
PEG Ratio (TTM) | 0.01 | 0.19 |
P/S Ratio (TTM) | 0.56 | 2.21 |
P/B Ratio (TTM) | 0.15 | 1.62 |
P/FCF Ratio (TTM) | -4.06 | 10.24 |
Price to 5YR AVG Earnings Ratio | N/A | 5.29 |
Price to 5YR AVG FCF Ratio | N/A | 8.19 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -14.85% | 6.41% |
ROE (TTM) | -14.26% | 9.77% |
Net Profit Margin (TTM) | -58.08% | 16.79% |
ROIC 5YR AVG | N/A | 13.22% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -210.09% | -186.93% | N/A |
Revenue | 9.57% | 406.97% | N/A |
Net Income | -786.72% | -220.02% | N/A |
Cash Flow | 84.28% | -17.11% | N/A |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 12.38 | 1.74 |
Quick Ratio (TTM) | 12.27 | 1.59 |
D/E Ratio (TTM) | -0.01 | 0.67 |
Interest Coverage (TTM) | -654.25 | 13.19 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 2.62 | 2.16 |
LTL to 5YR AVG FCF | N/A | 3.10 |
Shares Outstanding Growth 5YR AVG | N/A | 11.53% |